Important Alerts
Updates

Effective May 5, 2025, Podiatry in West New York will relocate to 201 State Rt 17 in Rutherford.

Effective April 28, 2025, Primary Care in Haddon Heights will relocate to 2 South Black Horse Pike in Mt. Ephraim.

Effective April 28, 2025, Cardiology in Haddon Heights will relocate to 322 Route 38, Cherry Hill.

Effective April 21, 2025 Pediatrics – Wall at 1560 State Route 138 will relocate to 3350 State Route 138.

Effective April 14, 2025 Primary Care – Voorhees has relocated to 165 S Black Horse Pike, Runnemede.

Effective April 14, 2025  Pediatrics – Manasquan has relocated to  3350 State Route 138 Wall.

As of April 7, 2025, Podiatry in Bayonne has relocated to 191 Lefante Way, Suite C in Bayonne.

As of April 7, 2025  Gastroenterology – Hackensack and Cardiology – Hackensack have relocated to 1 Maywood Avenue in Maywood.

As of April 7, 2025 Primary Care – Moorestown and Cardiology – Moorestown have relocated to Cherry Hill at 322 Route 38, Cherry Hill.

As of April 7,  2025,  Primary Care – Secaucus  and Gastroenterology – Secaucus have relocated to Rutherford at 201 Route 17 11th Floor Rutherford.

As of March 31, 2025, Primary Care – Rutherford has relocated to 201 Route 17, Suite 1102 in Rutherford.

As of March 28, 2025,  Primary Care – Roslyn has relocated to the Optum multi-specialty medical office location in Lake Success.

As of March 3, 2025, Pediatrics – Port Jefferson has relocated to 1500 Route 112, Building 1, Floor 1, in Port Jefferson.

As of March 3, 2025, Primary Care – Port Jefferson Station has relocated to 1500 Route 112, Building 1, Floor 1, in Port Jefferson.

Recording/Photography Not Permitted on Premises

Office and Urgent Care Closures

The Croton-on-Hudson lab is temporarily closed until further notice.

COVID-19 Information and Updates
View all

Myeloproliferative vs. myelodysplastic

  • Myeloproliferative disorders: Diseases where bone marrow generates too many of a specific type of blood cell.
  • Myelodysplastic disorders: Groups of cancers where the blood cells in the marrow do not mature to become healthy blood cells. In certain situations, these disorders can progress into leukemia.

Understanding your risk

The most important risk factor for these disorders is prior treatment with chemotherapy as certain drugs can make patients more susceptible especially to myelodysplastic disorders.

Like other cancers, your risk depends on many variables including:

  • Prior radiation therapy
  • Smoking
  • Exposure to high doses of radiation at work or home
  • Genetic syndromes or mutations

Optum offers comprehensive cancer risk assessments and hereditary cancer genetics evaluation programs to help you identify your risk. Start our online hereditary assessment now ›

Diagnosing MPD and MDS disorders

Because these disorders are found in the blood cells, they are most often detected through normal blood examinations. Based on initial tests, your doctor will use additional exams such as:

  • Blood cell counts
  • Bone marrow tests

Symptoms

The most common symptoms of these disorders are due to the abnormal blood counts. Further symptoms of these disorders may include:

  • Tiredness and shortness of breath
  • Lack of color (paleness) in skin
  • Easy bruising and bleeding
  • Frequent nose bleeds or bleeding from the gums
  • Excessive blood clotting like strokes, heart attacks and deep vein thrombosis

Treatments

For all of these cancers, the treatments are fairly similar. However, the exact treatment will be determined based on the severity and stage of the cancer. The most common treatments include:

  • Targeted Therapy: drugs that attack specific abnormalities within cancer cells or by directing your immune system to kill cancer cells.
  • Chemotherapy: chemicals administered in pill or IV form to kill and slow the growth of cancer cells

Learn more about our minimally-invasive robotic assisted surgery options ›

Medical care and help

To find a blood cell disease specialist near you, visit our Providers page.

Contact us if you have any questions.